We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Stellar Pharmaceuticals Receives 2nd Uracyst(R) Patent in United States of America

News   Jan 27, 2012

 
Stellar Pharmaceuticals Receives 2nd Uracyst(R) Patent in United States of America
 
 
Advertisement
 

RELATED ARTICLES

Computer Model Helps To Improve Injectability of Drug-delivering Particles

News

Researchers have developed a computational model that helps improve the injectability of microparticles and prevent them from clogging.

READ MORE

Mutated Form of SARS-CoV-2 Is Dominant, But Doesn't Make Patients Sicker, Study Says

News

In a collaborative research study, scientists show that a mutated version of SARS-CoV-2 has become the predominant form across the globe. Whilst the variant competes with the original strain, clinical data suggests that it does not make individuals sicker.

READ MORE

Safer and More Efficient Method To Deliver Gene Therapy

News

Madison researchers have developed a safer and more efficient way to deliver a promising new method for treating cancer and liver disorders and for vaccination.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE